Filed: 2/9/2023ACC: 0001766721-23-000001
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $151.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$151.47M
Total AUM (reported)
26.16M
Total Shares
Allocation by class
COM$111.46M73.6%
SPONSORED ADS$34.82M23.0%
COM CL A$4.88M3.2%
CL A COM$310.5K0.2%
Portfolio Concentration
Top 3$107.14M70.7%
4–10$39.95M26.4%
11–25$4.38M2.9%
Top 3 weight
70.7%
Top 10 weight
97.1%
Voting Authority Distribution
Total shares with voting rights: 26.16M
Sole
Full voting authority
26.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$46.24M
30.53%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.33M
TypeSH
Market value$34.82M
22.99%
Sole
1.33M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$26.09M
17.22%
Sole
1.02M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc. (GLUE)
SOLEShares1.47M
TypeSH
Market value$11.20M
7.40%
Sole
1.47M
Shared
0.00
None
0.00
Aclaris Theraputics Inc. (ACRS)
SOLEShares434.45K
TypeSH
Market value$6.84M
4.52%
Sole
434.45K
Shared
0.00
None
0.00
Biomea Fusion Inc. (BMEA)
SOLEShares798.76K
TypeSH
Market value$6.73M
4.45%
Sole
798.76K
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$5.53M
3.65%
Sole
1.04M
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$4.88M
3.22%
Sole
2.54M
Shared
0.00
None
0.00
Elevation Oncology Inc. (ELEV)
SOLEShares2.83M
TypeSH
Market value$2.69M
1.78%
Sole
2.83M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc. (RPHM)
SOLEShares886.08K
TypeSH
Market value$2.06M
1.36%
Sole
886.08K
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$1.32M
0.87%
Sole
1.21M
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares3.14M
TypeSH
Market value$848.6K
0.56%
Sole
3.14M
Shared
0.00
None
0.00
Aeglea Biotherapeutics Inc. (AGLE)
SOLEShares1.69M
TypeSH
Market value$761.0K
0.50%
Sole
1.69M
Shared
0.00
None
0.00
AVROBIO, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$716.9K
0.47%
Sole
1.01M
Shared
0.00
None
0.00
Viracta Therapeutics Inc. (VIRX)
SOLEShares288.57K
TypeSH
Market value$421.3K
0.28%
Sole
288.57K
Shared
0.00
None
0.00
Atreca Inc. (BCEL)
SOLEShares387.65K
TypeSH
Market value$310.5K
0.20%
Sole
387.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $46.24M 30.53% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.33M | SH | $34.82M 22.99% | 1.33M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $26.09M 17.22% | 1.02M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc. (GLUE)SOLE | COM | 1.47M | SH | $11.20M 7.40% | 1.47M | 0.00 | 0.00 |
Aclaris Theraputics Inc. (ACRS)SOLE | COM | 434.45K | SH | $6.84M 4.52% | 434.45K | 0.00 | 0.00 |
Biomea Fusion Inc. (BMEA)SOLE | COM | 798.76K | SH | $6.73M 4.45% | 798.76K | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $5.53M 3.65% | 1.04M | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $4.88M 3.22% | 2.54M | 0.00 | 0.00 |
Elevation Oncology Inc. (ELEV)SOLE | COM | 2.83M | SH | $2.69M 1.78% | 2.83M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc. (RPHM)SOLE | COM | 886.08K | SH | $2.06M 1.36% | 886.08K | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $1.32M 0.87% | 1.21M | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM | 3.14M | SH | $848.6K 0.56% | 3.14M | 0.00 | 0.00 |
Aeglea Biotherapeutics Inc. (AGLE)SOLE | COM | 1.69M | SH | $761.0K 0.50% | 1.69M | 0.00 | 0.00 |
AVROBIO, Inc. (AVRO)SOLE | COM | 1.01M | SH | $716.9K 0.47% | 1.01M | 0.00 | 0.00 |
Viracta Therapeutics Inc. (VIRX)SOLE | COM | 288.57K | SH | $421.3K 0.28% | 288.57K | 0.00 | 0.00 |
Atreca Inc. (BCEL)SOLE | CL A COM | 387.65K | SH | $310.5K 0.20% | 387.65K | 0.00 | 0.00 |